R. Douglas Norby, Director at ALEXION PHARMACEUTICALS INC (ALXN), sold 32,000 shares at $35.48 ($1.1M) on 2009-03-16, disclosed to the SEC on 2009-03-18.
Scheduled sale ($1.1M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.03 | 29,400 | $1.0M | 91.8% |
| 2 | $35.48 | 2,600 | $92K | 8.2% |
| Total | $35.07 avg | 32,000 | $1.1M | 100% |
| Filing → |
| ALXN | SELL | 2013-05-23 | $4.1M | — | Filing → |
| ALXN | SELL | 2012-12-12 | $2.0M | — | Filing → |
| ALXN | SELL | 2012-03-12 | $2.6M | — | Filing → |